Spots Global Cancer Trial Database for Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease
Official Title: A Multicenter, Randomized, Blinded Efficacy and Safety Study of Pasireotide LAR vs Octreotide LAR in Patients With Metastatic Carcinoid Tumors Whose Disease-related Symptoms Are Inadequately Controlled by Somatostatin Analogues.
Study ID: NCT00690430
Study Description
Brief Summary: The purpose of this randomized, multicenter, Phase III study was to compare the efficacy of paseriotide LAR and octreotide LAR in patients whose disease-related symptoms are inadequately controlled by currently available somatostatin analogues.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Scottsdale Healthcare/TGen Clinical Research Service TGen Clinical Research Service, Scottsdale, Arizona, United States
University of Arizona / Arizona Cancer Center, Tucson, Arizona, United States
Loma Linda University Dept. of Loma Linda CancerCent, Loma Linda, California, United States
Cedars Sinai Medical Center Cedars Sinai 4, Los Angeles, California, United States
H. Lee Moffitt Cancer Center/University of South Florida Dept of H. Lee Moffit, Tampa, Florida, United States
Montefiore Medical Center MMC, Bronx, New York, United States
Mount Sinai School of Medicine Study Coordinator, New York, New York, United States
Duke University Medical Center Dept. of Duke Cancer Center(2), Durham, North Carolina, United States
St. Luke's Hospital and Health Network St. Luke's Cancer Network, Bethlehem, Pennsylvania, United States
MD Anderson Cancer Center/University of Texas Dept. of MD Anderson (9), Houston, Texas, United States
Novartis Investigative Site, Buenos Aires, , Argentina
Novartis Investigative Site, Buenos Aires, , Argentina
Novartis Investigative Site, Graz, , Austria
Novartis Investigative Site, Salzburg, , Austria
Novartis Investigative Site, Vienna, , Austria
Novartis Investigative Site, Bruxelles, , Belgium
Novartis Investigative Site, Gent, , Belgium
Novartis Investigative Site, Fortaleza, CE, Brazil
Novartis Investigative Site, Calgary, Alberta, Canada
Novartis Investigative Site, Halifax, Nova Scotia, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Clichy, , France
Novartis Investigative Site, Dijon, , France
Novartis Investigative Site, Lyon, , France
Novartis Investigative Site, Marseille cedex 05, , France
Novartis Investigative Site, Montpellier cedex 5, , France
Novartis Investigative Site, Nice Cedex, , France
Novartis Investigative Site, Strasbourg, , France
Novartis Investigative Site, Bad Berka, , Germany
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Heidelberg, , Germany
Novartis Investigative Site, Mainz, , Germany
Novartis Investigative Site, München, , Germany
Novartis Investigative Site, Jerusalem, , Israel
Novartis Investigative Site, Bologna, BO, Italy
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Modena, MO, Italy
Novartis Investigative Site, Perugia, PG, Italy
Novartis Investigative Site, Roma, RM, Italy
Novartis Investigative Site, Orbassano, TO, Italy
Novartis Investigative Site, Tromsø, , Norway
Novartis Investigative Site, Trondheim, , Norway
Novartis Investigative Site, Gliwice, Slaskie, Poland
Novartis Investigative Site, Gdansk, , Poland
Novartis Investigative Site, Singapore, , Singapore
Novartis Investigative Site, Hospitalet de Llobregat, Cataluña, Spain
Novartis Investigative Site, Santiago de Compostela, Galicia, Spain
Novartis Investigative Site, Jönköping, , Sweden
Novartis Investigative Site, Linköping, , Sweden
Novartis Investigative Site, Lund, , Sweden
Novartis Investigative Site, Stockholm, , Sweden
Novartis Investigative Site, Stockholm, , Sweden
Novartis Investigative Site, Uppsala, , Sweden
Novartis Investigative Site, Withington, Greater Manchester, United Kingdom
Novartis Investigative Site, Sheffield, South Yorkshire, United Kingdom
Novartis Investigative Site, Basingstoke, , United Kingdom
Novartis Investigative Site, Birmingham, , United Kingdom
Novartis Investigative Site, Glasgow, , United Kingdom
Novartis Investigative Site, London, , United Kingdom
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
